Mandate

Vinge advises Active Biotech on rights offering

November 15, 2016

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million.
 
Vinge advises Active Biotech. Vinge’s team primarily consists of Erik Sjöman, Christian Lindhé, Ludvig Frithiof and Astrid Karlsson.

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024